Skip to main content

Advertisement

Log in

More than four decades of graft survival in pediatric kidney transplant recipients

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Early in the history of kidney transplantation, short-term graft survival was low. Yet some have had excellent long-term survival. Herein, we describe characteristics of pediatric recipients with > 40 years of graft survival currently alive with a functioning first graft.

Methods

We reviewed all pediatric (age < 18 years) kidney transplants performed at the University of Minnesota between January 1, 1970, and December 31, 1979 (n = 148), to identify all recipients currently alive with a functioning first graft. Data are presented as medians with interquartile ranges (IQR) and proportions.

Results

We identified 10 recipients with > 40-year graft survival (median follow-up: 45.0 years (IQR: 43.1, 48.1)). The median age at transplant was 13.8 years (IQR: 5.1, 16.3). All recipients were white; half were male. Of the 10, 4 had glomerulonephritis, 2 had congenital anomalies of the kidney and the urinary tract, 2 had congenital nephrotic syndrome, 1 had Alport syndrome, and 1 had cystic kidney disease as kidney failure cause. Nine patients received a living-related donor transplant, and 1 patient received a deceased-donor transplant. The median estimated glomerular filtration rate at 20 years post-transplant was 79.9 (IQR: 72.3, 98.4); at 30 years, 67.7 (IQR: 63.2, 91.8); and at 40 years, 80.3 ml/min/1.73 m2 (IQR: 73.7, 86.0). None developed rejection, 5 developed hypertension, 2 developed dyslipidemia, 1 developed diabetes, and 7 patients developed malignancy (4 skin cancer, 2 breast cancer, and 1 post-transplant lymphoproliferative disease).

Conclusion

Pediatric kidney transplant recipients may achieve > 4 decades of graft survival. Cancer is a common complication warranting vigilant screening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

Data are available from the corresponding author upon request.

References

  1. Papalois VE, Najarian JS (2001) Pediatric kidney transplantation: historic hallmarks and a personal perspective. Pediatr Transplant 5:239–245

    Article  CAS  PubMed  Google Scholar 

  2. Najarian JS, Simmons RL, Tallent MB, Kiellstrand CM, Buselmeier TJ, Vernier RL, Michael AF (1971) Renal transplantation in infants and children. Ann Surg 174:583–601

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Levey AS, Stevens LA (2010) Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 55:622–627

    Article  PubMed  PubMed Central  Google Scholar 

  4. Najarian JS, So SK, Simmons RL, Fryd DS, Nevins TE, Ascher NL, Sutherland DE, Payne WD, Chavers BM, Mauer SM (1986) The outcome of 304 primary renal transplants in children (1968–1985). Ann Surg 204:246–258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Serrano OK, Matas AJ (2017) Living donor kidney allograft survival ≥ 50 years. Clin Transplant 31. https://doi.org/10.1111/ctr.12938

  6. Spartà G, Hadaya K, Paunier L, Girardin E, Leumann E (2023) Deceased donor kidney transplanted in childhood functioning well after 52 years. Pediatr Nephrol 38:3489–3492

    Article  PubMed  PubMed Central  Google Scholar 

  7. Starzl TE, Murase N, Demetris AJ, Trucco M, Abu-Elmagd K, Gray EA, Eghtesad B, Shapiro R, Marcos A, Fung JJ (2004) Lessons of organ-induced tolerance learned from historical clinical experience. Transplantation 77:926–929

    Article  PubMed  PubMed Central  Google Scholar 

  8. Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sørensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, Mühlfeld A, Orlando G, Clemente K, Lai Q, Pisani F, Kandus A, Baas M, Bemelman F, Ponikvar JB, Mazouz H, Stratta P, Subra JF, Villemain F, Hoitsma A, Braun L, Cantarell MC, Colak H, Courtney A, Frasca GM, Howse M, Naesens M, Reischig T, Serón D, Seyahi N, Tugmen C, Alonso Hernandez A, Beňa L, Biancone L, Cuna V, Díaz-Corte C, Dufay A, Gaasbeek A, Garnier A, Gatault P, GentilGovantes MA, Glowacki F, Gross O, de Ligny BH, Huynh-Do U, Janbon B, Del Cerro LAJ, Keller F, La Manna G, Lauzurica R, Le Monies De Sagazan H, Thaiss F, Legendre C, Martin S, Moal M-C, Noël C, Pillebout E, Piredda GB, Puga AR, Sulowicz W, Tuglular S, Prokopova M, Chesneau M, Le Moine A, Guérif P, Soulillou J-P, Abramowicz M, Giral M, Racapé J, Maggiore U, Brouard S, Abramowicz D (2016) The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. Nephrol Dial Transplant 31:1002–1013

    Article  PubMed  Google Scholar 

  9. Massart A, Ghisdal L, Abramowicz M, Abramowicz D (2017) Operational tolerance in kidney transplantation and associated biomarkers. Clin Exp Immunol 189:138–157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW (2012) Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney Transplant. Am J Transplant 12:1157–1167

    Article  CAS  PubMed  Google Scholar 

  11. Ponticelli C, Campise MR (2021) The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation. Kidney Int 100:536–545

    Article  CAS  PubMed  Google Scholar 

  12. Robinson C, Chanchlani R, Kitchlu A (2021) Malignancies after pediatric solid organ transplantation. Pediatr Nephrol 36:2279–2291

    Article  PubMed  Google Scholar 

  13. Wong G, Au E, Badve SV, Lim WH (2017) Breast cancer and transplantation. Am J Transplant 17:2243–2253

    Article  CAS  PubMed  Google Scholar 

  14. Suszynski TM, Rizzari MD, Gillingham KJ, Rheault MN, Kraszkiewicz W, Matas AJ, Chavers BM (2013) Antihypertensive pharmacotherapy and long-term outcomes in pediatric kidney transplantation. Clin Transplant 27:472–480

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hryniewiecka E, Zegarska J, Zochowska D, Samborowska E, Jazwiec R, Kosieradzki M, Nazarewski S, Dadlez M, Paczek L (2018) Cardiovascular disease in kidney transplantation and its association with blood concentrations of cyclosporine and cyclosporine metabolites. Transplant Proc 50:1850–1854

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarah Kizilbash.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kizilbash, S., Rheault, M., Matas, A. et al. More than four decades of graft survival in pediatric kidney transplant recipients. Pediatr Nephrol 39, 631–635 (2024). https://doi.org/10.1007/s00467-023-06153-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-023-06153-z

Navigation